The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Similar Posts
Early Alert: Blood Pump Controller Issue from Abiomed
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramFDA In Brief: Findings from Real-World Data Study Reveal Higher Risk of Hospitalization and Death Among Cancer Patients with COVID-19, Underscore Health Disparities
FDA and Syapse presented Real-World Data at the American Association of Clinical Research (AACR) COVID-19 and Cancer meeting. Findings from study reveal higher risk of hospitalization and death among cancer patients with COVID-19.ZapMax may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use ZapMax, a product promoted and sold for sexual enhancement on various websites, including www.amazon.com, and possibly in some retail stores.www.d-pharmacy.com – 711075 – 07/16/2025
Unapproved New Drugs/MisbrandedAnhui Hanbon Daily Chemical Co., Ltd. – 708903 – 08/11/2025
CGMP/Finished Pharmaceuticals/AdulteratedHospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (Containing Benzyl Alcohol), Due To The Potential Presence of Visible Particulates
Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol), 100mL Single Patient Use Glass Fliptop Vial; lot EA7470, to the user level due to visible particulates observed in two vials during annual examination of retention samples.